Navigation Links
LCA-Vision Announces Termination of Consent Solicitation and Withdrawal of Dissident Slate of Director Nominees
Date:3/30/2009

CINCINNATI, March 30 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus(R) brand, today announced that, according to a March 26, 2009 filing with the Securities and Exchange Commission, the dissident Joffe Group announced it has terminated its solicitation of written consents from LCA-Vision stockholders and that the Group has disbanded. Additionally, the Joffe Group stated that it has withdrawn its slate of Board of Director nominees for election at the LCA-Vision 2009 Annual Meeting. As of March 26, 2009, other than its own votes, the Joffe Group received votes totaling 6% of LCA-Vision's outstanding shares.

"We appreciate the support we received from our stockholders, surgeons, optometrists and staff during the consent solicitation process and are happy to put this matter behind us," said Steven Straus, LCA-Vision chief executive officer. "We are now able to focus 100% of our attention on our business, working closely with our Medical Advisory Board, Optometric Advisory Board, surgeons, optometrists and all LCA-Vision / LasikPlus(R) staff members to manage through challenging economic times and prepare for future success."

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 75 LasikPlus(R) fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

Earning Trust Every Moment.

Transforming Lives Every Day.

    For Additional Information

    Company Contact:                     Investor Relations Contact:
    Barb Kise                            Jody Cain
    LCA-Vision Inc.                      Lippert/Heilshorn & Associates
    513-792-9292                         310-691-7100


'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RiskMetrics Affirms Recommendation that Stockholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
2. LCA-Visions Medical Advisory Board Voices Support for Current Management
3. Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors
4. LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually
5. The LCA-Vision Full Value Committee Urges LCA-Vision (NASDAQ: LCAV) Stockholders to Reject the Status Quo
6. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
7. LCA-Vision to Present at the Raymond James 30th Annual Institutional Investors Conference
8. Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group
9. The LCA-Vision Full Value Committee Files Detailed Presentations
10. LCA-Vision Reports Tangible Results from Business Strategy
11. LCA-Vision Announces Appointment of Edgar F. Heizer to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) announced today ... Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, value-based care, and ... analytics solutions. , “I am thrilled to welcome Dr. Spiro to BHI,” said ...
(Date:8/16/2017)... ... 16, 2017 , ... The Data Council, the leading provider ... acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the Specialty, ... leading suppliers, brokers, distributors and retailers. The Data Council will become a part ...
(Date:8/16/2017)... York, New York (PRWEB) , ... August 16, 2017 , ... ... they could minimize its appearance with diet and exercise. In fact, cellulite can't always ... is a safer and more effective treatment available to select physicians nationwide. Dr. Kenneth ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Southeastern ... three-year grant totaling $975,000, renewing its funding from the Health Resources and Services ... This funding marks, the fourth time the HRSA administration has renewed its financial ...
(Date:8/16/2017)... , ... August 16, 2017 , ... With a new ... and ultimately, a cure. , The grants are awarded through a competitive application ... with a wide array of backgrounds and expertise in all areas relevant to PD ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
Breaking Medicine Technology: